use laboratori marker surrog clinic endpoint evalu treatment hiv infect strong ethic practic reason decision-mak efficaci new treatment human immunodefici viru hiv infect strategi earli marker diseas progress lymphocyt level surrog ultim clinic endpoint develop immun defici syndrom aid death evalu new therapi simpl model transit health state aliv advers marker definit clinic endpoint extent treatment comparison surrog endpoint predict ultim clinic benefit paramet treatment hiv infect comput simul clinic trial substanti time save use surrog endpoint relianc surrog seriou overestim ultim clinic benefit treatment delay toxic transient benefici effect likewis relianc surrog seriou underestim ultim clinic benefit treatment effect transit marker state rate transit marker state ultim clinic endpoint well state ultim clinic endpoint 